Trials / Unknown
UnknownNCT04248309
Serum Progesterone Level in HRT-FET:a RCT
The Effect of Serum Progesterone Level on Day 3 in HRT-FET Cycles on the Clnical Outcome: a Randomized Controlled Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 423 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 41 Years
- Healthy volunteers
- Not accepted
Summary
In the window of implantation, progesterone plays an important role. Sufficient serum progesterone is basic for ongoing pregnancy. Vaginal progesterone is more and more widely used in ART. As it has no hepatic first pass effect. What is the optimal serum level for pregnancy when use vaginal progesterone is not known yet? Hormone replacement therapy- FET is the optimal strategy to explore this question. There are some retrospective studies showed that the serum progesterone level on embryo transfer day (D3 or D5) or pregnancy test day (D14) lower than 10-11ng/ml is significantly associated with ongoing pregnancy rate in HRT-FET cycles. This prospective study is designed to compare the ongoing pregnancy rate between different serum progesterone levels on D3 and to explore the intervention of additional progesterone supplement since D3 is helpful in HRT-FET cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intramuscular progesterone 20-40mg from D3 until pregnancy test | serum progesterone \<7.24ug/L, followed by randomized A1: plus additional treatment(intramuscular progesterone 20-40mg from D3 ) |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2021-03-01
- Completion
- 2021-04-01
- First posted
- 2020-01-30
- Last updated
- 2020-01-30
Source: ClinicalTrials.gov record NCT04248309. Inclusion in this directory is not an endorsement.